+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Patient characteristics and statin discontinuation-related factors during treatment of hypercholesterolemia: an observational non-interventional study in patients with statin discontinuation (STAY study)



Patient characteristics and statin discontinuation-related factors during treatment of hypercholesterolemia: an observational non-interventional study in patients with statin discontinuation (STAY study)



Turk Kardiyoloji Dernegi Arsivi 44(1): 53-64



The purpose of this study was to identify patient characteristics and statin discontinuation-related factors in patients with hypercholesterolemia. A total of 532 patients (age mean±SD: 57.4±11.5 years; 52.4% women, 47.6% men) with hypercholesterolemia and statin discontinuation were included in this national cross-sectional non-interventional observational study. Data on socio-demographic characteristics of patients, cardiovascular risk factors, past treatment with and discontinuation of statin treatment were collected in one visit. Mean±SD duration of hypercholesterolemia was 4.9±4.2 years at time of discontinuation of statin treatment. Statin treatment was initiated by cardiologists in the majority of cases (55.8%), whereas discontinuation of statin treatment was decided by patients in the majority of cases (73.7%), with patients with higher (at least secondary education, 80.4%) more likely than those with lower (only primary education, 69.7%) to decide to discontinue treatment (p=0.022). Negative information about statin treatment disseminated by TV programs-mostly regarding coverage of hepatic (38.0%), renal (33.8%), and muscular (32.9%) side effects (32.9%)-was the most common reason for treatment discontinuation. The decision to discontinue statin treatment was made at the patient's discretion in 74% of cases, with higher likelihood of patients with higher educational status deciding to discontinue treatment and switch to non-drug lipid-lowering alternatives. Cardiologists were the physicians most frequently responsible for the initiation of the statin treatment; coverage of several non-life-threatening statin side effects by TV programs and patients' lack of information regarding high cholesterol and related risks were the leading factors predisposing to treatment discontinuation.

(PDF emailed within 1 workday: $29.90)

Accession: 058512401

Download citation: RISBibTeXText

PMID: 26875131


Related references

Predictors of Statin Adherence, Switching, and Discontinuation in the USAGE Survey Understanding Statin Use in America and Gaps in Patient Education. Journal of Clinical Lipidology 7(3): 245-246, 2013

Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuation. Biofactors 25(1-4): 147-152, 2006

Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event. American Journal of Cardiology 114(6): 826-831, 2014

Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database. Bmj 353: I3305, 2017

Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage. Bmj Open 2(3), 2012

Statin discontinuation and mortality in an older adult population with traumatic brain injury: A four-year, multi-centre, observational cohort study. Injury 48(5): 1040-1046, 2016

Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study. Arthritis Care and Research 64(6): 809-816, 2012

Discontinuation of statin treatment in stroke patients. Stroke 37(10): 2640-2643, 2006

Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study. Annals of the Rheumatic Diseases 70(6): 1020-1024, 2011

Predictors of first-year statin medication discontinuation: A cohort study. Journal of Clinical Lipidology 10(4): 987-995, 2017

Statin Discontinuation after Achieving a Target Low Density Lipoprotein Cholesterol Level in Type 2 Diabetic Patients without Cardiovascular Disease: A Randomized Controlled Study. Diabetes and Metabolism Journal 38(1): 64-73, 2014

Factors associated with discontinuation of aripiprazole treatment after switching from other antipsychotics in patients with chronic schizophrenia: A prospective observational study. Psychiatry Research 236: 71-74, 2016

Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale. Lipids in Health and Disease 16(1): 121, 2018

Match-study of statin therapy in spontaneous intracerebral hemorrhage: is the discontinuation reasonable?. Journal of Neurosurgical Sciences 60(3): 301-312, 2017

Discontinuation of statin therapy following an acute myocardial infarction: a population-based study. European Heart Journal 29(17): 2083-2091, 2008